279 related articles for article (PubMed ID: 16778101)
1. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
2. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
3. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
Kato K; Hida Y; Miyamoto M; Hashida H; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
Cancer; 2002 Feb; 94(4):929-33. PubMed ID: 11920460
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
6. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma.
Natsugoe S; Nakashima S; Matsumoto M; Xiangming C; Okumura H; Kijima F; Ishigami S; Takebayashi Y; Baba M; Takao S; Aikou T
Clin Cancer Res; 1999 Sep; 5(9):2445-9. PubMed ID: 10499617
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
[TBL] [Abstract][Full Text] [Related]
9. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
10. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T
Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
14. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic expression of type VII collagen is related to prognosis in patients with esophageal squamous cell carcinoma.
Baba Y; Iyama K; Honda S; Ishikawa S; Miyanari N; Baba H
Oncology; 2006; 71(3-4):221-8. PubMed ID: 17652943
[TBL] [Abstract][Full Text] [Related]
17. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
18. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T
Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
